Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy
By reducing chronic inflammation and supporting cellular repair, it helps the body fend off infections and recover faster from illnesses
Health 114, 109110
IGF-1 promotes protein synthesis, improves nitrogen retention, and increases muscle cell proliferation, leading to lean muscle gains and greater muscle density
US$ 24.61
US$ 25.45
US$ 25.14
US$ 23.70
US$ 19.99
